Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Rationale and design for a phase IIIb trial of first-line tremelimumab plus durvalumab versus pembrolizumab, in combination with chemotherapy, in patients with non-squamous metastatic non-small-cell lung cancer and mutations or co-mutations in STK11, KEAP1, or KRAS: the TRITON study.
Journal: Therapeutic advances in medical oncology
Published: May 01, 2025
The value of real-world evidence in supporting targeted therapies for patients with rare oncogenic drivers in mNSCLC.
Journal: Future oncology (London, England)
Published: March 14, 2025
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 27, 2023
Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non‑Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast.
Journal: Targeted oncology
Published: December 09, 2023
Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast.
Journal: Targeted oncology
Published: October 27, 2023
Real-world relationship of early end points to survival end points in patients with resectable non-small-cell lung cancer.
Journal: Future oncology (London, England)
Published: September 04, 2023
EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast.
Journal: Targeted oncology
Published: August 17, 2023
Real-world study of patients with locally advanced HNSCC in the community oncology setting.
Journal: Frontiers in oncology
Published: January 31, 2023
Treatment patterns and outcomes in metastatic synovial sarcoma: a real-world study in the US oncology network.
Journal: Future oncology (London, England)
Published: August 26, 2022
Real-world patterns of biomarker testing and targeted therapy in de novo metastatic non-small cell lung cancer patients in the US oncology network.
Journal: Cancer treatment and research communications
Published: November 30, 2021
Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 12, 2021
Last Updated: 09/26/2026